Skip to main content
Erschienen in: International Urogynecology Journal 4/2021

13.10.2020 | Original Article

Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users

verfasst von: Lanuza Celes Mendes, Leonardo Robson Pinheiro Sobreira Bezerra, Andreisa Paiva Monteiro Bilhar, José Ananias Vasconcelos Neto, Camila Teixeira Moreira Vasconcelos, Dayana Maia Saboia, Sara Arcanjo Lino Karbage

Erschienen in: International Urogynecology Journal | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The vaginal pessary is a conservative method for treating pelvic organ prolapse (POP). It is able to reduce symptoms with minimal complications, improving quality of life (QOL). This study’s hypothesis was that the use of pessaries decreases quantitative measures and improves women’s QOL. We aimed to evaluate the effects of the use of a ring pessary on the quantitative measurements of POP by the Pelvic Organ Prolapse Quantification (POP-Q) and on QOL.

Methods

Prospective cohort study divided in two stages. In stage I POP-Q and QOL were assessed prior to the use of the ring pessary and in stage II after its use for at least 4 months with pessary removal 72 h before clinical evaluation. Wilcoxon tests were performed for necessary comparisons and Spearman’s tests for calculating correlations.

Results

One hundred thirty-six women were evaluated, of which 50 were included. There was a decrease in POP in at least one of the vaginal compartments in the women included. When assessing individual measures (Ba, Bp and C), reductions in all measures were observed. There was also an improvement in the general and specific quality of life of women.

Conclusion

The ring pessary proved to be a good therapeutic option, with a reduction in POP-Q measurements and/or absence of POP progression in the short term and an improvement in women’s QOL.
Literatur
1.
Zurück zum Zitat Abrams P, Cardoso L, Khoury S, Wein A. Incontinence. Tokyo: ICUD; 2017. Abrams P, Cardoso L, Khoury S, Wein A. Incontinence. Tokyo: ICUD; 2017.
5.
Zurück zum Zitat Yang JF, Han JS, Zhu FL, Wang YT, Yao Y, Qiao J. Clinical study on silicone pessary in the treatment of pelvic organ prolapse. Zhonghua Fu Chan Ke Za Zhi. 2012;47:487–91.PubMed Yang JF, Han JS, Zhu FL, Wang YT, Yao Y, Qiao J. Clinical study on silicone pessary in the treatment of pelvic organ prolapse. Zhonghua Fu Chan Ke Za Zhi. 2012;47:487–91.PubMed
6.
Zurück zum Zitat Babet HCL, Bart MWB, Alfredo LM. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011;22:637–44.CrossRef Babet HCL, Bart MWB, Alfredo LM. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011;22:637–44.CrossRef
10.
Zurück zum Zitat Handa VL, Jones M. Do pessaries prevent the progression of pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:349–51.CrossRef Handa VL, Jones M. Do pessaries prevent the progression of pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:349–51.CrossRef
12.
Zurück zum Zitat Ciconelli RM, Ferraz MB, Santos N, Meinão I, Quaresma MR. Tradução para a língua portuguesa do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1994;39:143–50. Ciconelli RM, Ferraz MB, Santos N, Meinão I, Quaresma MR. Tradução para a língua portuguesa do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1994;39:143–50.
14.
Zurück zum Zitat Hall A, Theofrastous J, Cundiff G, Harris R, Hamilton L, Swift S, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol. 1966;175:1467–71.CrossRef Hall A, Theofrastous J, Cundiff G, Harris R, Hamilton L, Swift S, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol. 1966;175:1467–71.CrossRef
15.
Zurück zum Zitat Matsubara S, Ohki Y. Can a ring pessary have a lasting effect to reverse uterine prolapse even after its removal? J Obstet Gynaecol Res. 2010;36:459–61.CrossRef Matsubara S, Ohki Y. Can a ring pessary have a lasting effect to reverse uterine prolapse even after its removal? J Obstet Gynaecol Res. 2010;36:459–61.CrossRef
19.
Zurück zum Zitat Komesu YM, Rogers RG, Rode MA, Craig EC, Gallegos KA, Montoya AR, et al. Pelvic floor symptom changes in pessary users. Am J Obstet Gynecol. 2007;197:1–6.CrossRef Komesu YM, Rogers RG, Rode MA, Craig EC, Gallegos KA, Montoya AR, et al. Pelvic floor symptom changes in pessary users. Am J Obstet Gynecol. 2007;197:1–6.CrossRef
Metadaten
Titel
Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users
verfasst von
Lanuza Celes Mendes
Leonardo Robson Pinheiro Sobreira Bezerra
Andreisa Paiva Monteiro Bilhar
José Ananias Vasconcelos Neto
Camila Teixeira Moreira Vasconcelos
Dayana Maia Saboia
Sara Arcanjo Lino Karbage
Publikationsdatum
13.10.2020
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 4/2021
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-020-04540-w

Weitere Artikel der Ausgabe 4/2021

International Urogynecology Journal 4/2021 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.